Skip Header

1 - 25 of 50 results for author:"Date H." in Literature citations

Page of 2 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (9)

The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement.

Ishiura H., Sako W., Yoshida M., Kawarai T., Tanabe O., Goto J., Takahashi Y., Date H., Mitsui J., Ahsan B. et al.

Am. J. Hum. Genet. 91:320-329(2012) · UniProtKB (3) · Mapped (4)

Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.

Ishikawa M., Miyahara R., Sonobe M., Horiuchi M., Mennju T., Nakayama E., Kobayashi M., Kikuchi R., Kitamura J., Imamura N. et al.

Lung Cancer 76:431-438(2012) · Mapped (8)

Clinical significance of BRAF gene mutations in patients with non-small cell lung cancer.

Kobayashi M., Sonobe M., Takahashi T., Yoshizawa A., Ishikawa M., Kikuchi R., Okubo K., Huang C.L., Date H.

Anticancer Res. 31:4619-4623(2011) · Mapped (3)

Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma.

Menju T., Hashimoto S., Hashimoto A., Otsuka Y., Handa H., Ogawa E., Toda Y., Wada H., Date H., Sabe H.

PLoS ONE 6:e25301-e25301(2011) · Mapped (10)

A NOD2 gene polymorphism is associated with the prevalence and severity of chronic obstructive pulmonary disease in a Japanese population.

Kinose D., Ogawa E., Hirota T., Ito I., Kudo M., Haruna A., Marumo S., Hoshino Y., Muro S., Hirai T. et al.

Respirology 17:164-171(2012) · Mapped (11)

Impact of KRAS and EGFR gene mutations on recurrence and survival in patients with surgically resected lung adenocarcinomas.

Sonobe M., Kobayashi M., Ishikawa M., Kikuchi R., Nakayama E., Takahashi T., Menju T., Takenaka K., Miyahara R., Huang C.L. et al.

Ann. Surg. Oncol. 19 Suppl 3:S347-54(2012) · Mapped (26)

CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease.

Matsumoto L., Takuma H., Tamaoka A., Kurisaki H., Date H., Tsuji S., Iwata A.

PLoS ONE 5:e15522-e15522(2010) · Mapped (7)

Large solitary fibrous tumor with overexpression of insulin-like growth factor-2.

Okabe R., Sonobe M., Bando T., Date H.

Interact Cardiovasc Thorac Surg 11:688-690(2010) · Mapped (3)

Mutations in Keap1 are a potential prognostic factor in resected non-small cell lung cancer.

Takahashi T., Sonobe M., Menju T., Nakayama E., Mino N., Iwakiri S., Nagai S., Sato K., Miyahara R., Okubo K. et al.

J Surg Oncol 101:500-506(2010) · Mapped (1)

Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene.

Takahashi T., Sonobe M., Kobayashi M., Yoshizawa A., Menju T., Nakayama E., Mino N., Iwakiri S., Sato K., Miyahara R. et al.

Ann. Surg. Oncol. 17:889-897(2010) · Mapped (39)

Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment.

Jida M., Toyooka S., Mitsudomi T., Takano T., Matsuo K., Hotta K., Tsukuda K., Kubo T., Yamamoto H., Yamane M. et al.

Cancer Sci. 100:1931-1934(2009) · Mapped (19)

A disintegrin and metalloprotease 12 (ADAM12) is a prognostic factor in resected pathological stage I lung adenocarcinoma.

Mino N., Miyahara R., Nakayama E., Takahashi T., Takahashi A., Iwakiri S., Sonobe M., Okubo K., Hirata T., Sehara A. et al.

J Surg Oncol 100:267-272(2009) · Mapped (2)

Intranuclear degradation of polyglutamine aggregates by the ubiquitin-proteasome system.

Iwata A., Nagashima Y., Matsumoto L., Suzuki T., Yamanaka T., Date H., Deoka K., Nukina N., Tsuji S.

J. Biol. Chem. 284:9796-9803(2009) · Mapped (4)

Comprehensive analysis of EGFR signaling pathways in Japanese patients with non-small cell lung cancer.

Hosokawa S., Toyooka S., Fujiwara Y., Tokumo M., Soh J., Takigawa N., Hotta K., Yoshino T., Date H., Tanimoto M. et al.

Lung Cancer 66:107-113(2009) · Mapped (19)

MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.

Kubo T., Yamamoto H., Lockwood W.W., Valencia I., Soh J., Peyton M., Jida M., Otani H., Fujii T., Ouchida M. et al.

Int. J. Cancer 124:1778-1784(2009) · Mapped (41)

The aberrant promoter methylation of BMP3b and BMP6 in malignant pleural mesotheliomas.

Kimura K., Toyooka S., Tsukuda K., Yamamoto H., Suehisa H., Soh J., Otani H., Kubo T., Aoe K., Fujimoto N. et al.

Oncol. Rep. 20:1265-1268(2008) · Mapped (9)

PIK3CA mutations and copy number gains in human lung cancers.

Yamamoto H., Shigematsu H., Nomura M., Lockwood W.W., Sato M., Okumura N., Soh J., Suzuki M., Wistuba I.I., Fong K.M. et al.

Cancer Res. 68:6913-6921(2008) · Mapped (7)

REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.

Kawasaki K., Watanabe M., Sakaguchi M., Ogasawara Y., Ochiai K., Nasu Y., Doihara H., Kashiwakura Y., Huh N.H., Kumon H. et al.

Cancer Gene Ther. 16:65-72(2009) · Mapped (18)

Non-BAC component but not epidermal growth factor receptor gene mutation is associated with poor outcomes in small adenocarcinoma of the lung.

Kobayashi N., Toyooka S., Ichimura K., Soh J., Yamamoto H., Matsuo K., Otani H., Jida M., Kubo T., Tsukuda K. et al.

J Thorac Oncol 3:704-710(2008) · Mapped (19)

Detection of EGFR gene mutations using the wash fluid of CT-guided biopsy needle in NSCLC patients.

Otani H., Toyooka S., Soh J., Yamamoto H., Suehisa H., Kobayashi N., Gobara H., Mimura H., Kiura K., Sano Y. et al.

J Thorac Oncol 3:472-476(2008) · Mapped (19)

Dissection of the APCCdh1-Skp2 cascade in breast cancer.

Fujita T., Liu W., Doihara H., Date H., Wan Y.

Clin. Cancer Res. 14:1966-1975(2008) · Mapped (9)

Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung.

Soh J., Toyooka S., Ichihara S., Asano H., Kobayashi N., Suehisa H., Otani H., Yamamoto H., Ichimura K., Kiura K. et al.

J Thorac Oncol 3:340-347(2008) · Mapped (19)

Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma.

Toyooka S., Takano T., Kosaka T., Hotta K., Matsuo K., Ichihara S., Fujiwara Y., Soh J., Otani H., Kiura K. et al.

Cancer Sci. 99:303-308(2008) · Mapped (19)

Single nucleotide polymorphism in the RAD18 gene and risk of colorectal cancer in the Japanese population.

Kanzaki H., Ouchida M., Hanafusa H., Sakai A., Yamamoto H., Suzuki H., Yano M., Aoe M., Imai K., Date H. et al.

Oncol. Rep. 18:1171-1175(2007) · Mapped (2)

The impact of sex and smoking status on the mutational spectrum of epidermal growth factor receptor gene in non small cell lung cancer.

Toyooka S., Matsuo K., Shigematsu H., Kosaka T., Tokumo M., Yatabe Y., Ichihara S., Inukai M., Suehisa H., Soh J. et al.

Clin. Cancer Res. 13:5763-5768(2007) · Mapped (19)

to top of page·

Page of 2 | Next »